Amends TCA Title 8; Title 53; Title 56; Title 63; Title 68 and Title 71.

Tennessee SB0428 amends various sections of the Tennessee Code Annotated to authorize insurers offering group insurance plans to adopt or amend a state preferred drug list (PDL) that ensures non-opioid drugs approved by the FDA for pain management are not disadvantaged compared to opioid drugs. The bill affects insurers, healthcare providers, and patients covered under group insurance plans. Key provisions include requiring insurers to ensure reimbursement for non-opioid treatments and applying the bill's provisions to non-opioid drugs after they have been FDA approved for at least nine months.